Latest News

HOUSTON, TX ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments...
Houston, Texas – Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumor at the time of surgery and promising long-term survival, according to Phase II trial results published today in Nature Cancer by researchers at The University of Texas MD Anderson Cancer Center. After treatment...
TRENTO, Italy – “New windows of knowledge on ALS that pave the way for innovative possibilities in diagnosis, prognosis, and therapy.” With these words, researcher Manuela Basso summarizes the significance of a newly published study that deepens understanding of Amyotrophic Lateral Sclerosis (ALS), particularly the molecular mechanisms behind its slower-progressing...
Salt Lake City, Utah – Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC), a particularly aggressive disease. Their research, published in JCO...